Abstract | BACKGROUND: METHODS: The International Reduction of Atherothrombosis for Continued Health (REACH) Registry included 23,542 outpatients in Europe with established coronary artery disease, cerebrovascular disease (CVD), PAD and/or > or =3 risk factors. Of these, 3753 patients had symptomatic PAD. CV risk factors were determined at baseline. Study end point was a combination of cardiac death, non-fatal myocardial infarction (MI) and stroke (CV events) during 2 years of follow-up. Cox regression analysis adjusted for age, gender and other risk factors (i.e., congestive heart failure, coronary artery re-vascularisation, coronary artery bypass grafting (CABG), MI, hypertension, stroke, current smoking and diabetes) was used. RESULTS: Of 3753 PAD patients, 392 (10%) were known to have AF. Patients with AF were older and had a higher prevalence of CVD, diabetes and hypertension. Long-term CV mortality occurred in 5.6% of patients with AF and in 1.6% of those without AF (p<0.001). Multivariable analyses showed that AF was an independent predictor of late CV events (hazard ratio (HR): 1.5; 95% confidence interval (CI): 1.09-2.0). CONCLUSION: AF is common in European patients with symptomatic PAD and is independently associated with a worse 2-year CV outcome.
|
Authors | T A Winkel, S E Hoeks, O Schouten, U Zeymer, T Limbourg, I Baumgartner, D L Bhatt, Ph G Steg, S Goto, J Röther, P P Cacoub, H J M Verhagen, J J Bax, D Poldermans |
Journal | European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
(Eur J Vasc Endovasc Surg)
Vol. 40
Issue 1
Pg. 9-16
(Jul 2010)
ISSN: 1532-2165 [Electronic] England |
PMID | 20385507
(Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved. |
Chemical References |
|
Topics |
- Aged
- Aged, 80 and over
- Atrial Fibrillation
(complications, drug therapy, mortality)
- Cardiovascular Agents
(therapeutic use)
- Cardiovascular Diseases
(etiology, mortality)
- Chi-Square Distribution
- Europe
(epidemiology)
- Female
- Humans
- Male
- Middle Aged
- Myocardial Infarction
(etiology, mortality)
- Outpatients
- Peripheral Vascular Diseases
(complications, drug therapy, mortality)
- Prevalence
- Prognosis
- Proportional Hazards Models
- Prospective Studies
- Registries
- Risk Assessment
- Risk Factors
- Stroke
(etiology, mortality)
- Time Factors
|